L-Dopa did not cause malignant melanoma progression in a patient. Re-examination suggests recurrent lesions were metastases, not new melanomas, and L-Dopa was not involved.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Observation:
Findings:
Implications: